Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
Zongbi Yi(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(XinHua Hospital), Wenna Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingtong Zhai(Chinese Academy of Medical Sciences & Peking Union Medical College), Lifeng Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Guohua Rong(Chinese Academy of Medical Sciences & Peking Union Medical College), Haili Qian(Chinese Academy of Medical Sciences & Peking Union Medical College), Binliang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lianpeng Chang, Jin Li(Fudan University), Hui Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunxiao Li(Chinese Academy of Agricultural Sciences), Xin Yi(North China University of Science and Technology Affiliated Hospital), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ling Yang, Quchang Ouyang(Central South University), Xuefeng Xia(Nanjing Drum Tower Hospital), Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanfang Guan(Xi'an Jiaotong University), Lixi Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 74
Related Papers
The diploid genome sequence of an Asian individual
|Nature|2008|960
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis
|Nature Medicine|2016|791
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
|Nature Communications|2020|641
Genetic evidence supports demic diffusion of Han culture
|Nature|2004|482